Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients

International Journal of Cancer

Volumn 134, Issue 4, 2014, Pages 925-931

  Fehm, Tanja ^a   Banys, Malgorzata ^a,b   Rack, Brigitte ^c   Jäger, Bernadette ^d   Hartkopf, Andreas ^e   Taran, Florin Andrei ^e   Janni, Wolfgang ^d  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Marien Krankenhaus Hamburg   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF ULM   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

bone marrow; cervical cancer; disseminated tumor cell; overall survival; progression free survival

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE; MAJOR CLINICAL STUDY; METASTASIS; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESECTION STATUS; TUMOR CELL; TUMOR VOLUME; UTERINE CERVIX CANCER; VERY ELDERLY; YOUNG ADULT;

EID: 84890127695     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28417     Document Type: Article

References (30)

1. Braun S, Vogl FD, Naume B, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 2005; 353: 793-802.
2. Banys M, Solomayer EF, Becker S, et al. Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies. Int J Gynecol Cancer 2009; 19: 948-52.
3. Janni W, Hepp F, Strobl B, et al. Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus. Cancer 2003; 97: 405-11.
4. Globocan. Estimated Cancer Incidence, Mortality, Prevalence and Disability-adjusted life years (DALYs) Worldwide: IARC Cancer Epidemiology Database, World Health Organization, 2008.
5. Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006; 95(Suppl 1): S43-103.
6. Abdul-Karim FW, Kida M, Wentz WB, et al. Bone metastasis from gynecologic carcinomas: a clinicopathologic study. Gynecol Oncol 1990; 39: 108-14.
7. Fehm T, Becker S, Bachmann C, et al. Detection of disseminated tumor cells in patients with gynecological cancers. Gynecol Oncol 2006; 103: 942-7.
8. Fehm T, Braun S, Muller V, et al. A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer 2006; 107: 885-92.
9. Gallup D,. The Spread and Staging of Cervical Cancer. Glob. libr. women's med 2008.
10. Baid BL, Kumar L, Chander S, et al. Bone metastases in the patients of carcinoma cervix. Indian J Cancer 1992; 29: 71-5.
11. Braun S, Schindlbeck C, Hepp F, et al. Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse. J Clin Oncol 2001; 19: 368-75.
12. Fehm T, Banys M, Rack B, et al. Pooled Analysis of the Prognostic Relevance of Disseminated Tumor Cells in the Bone Marrow of Patients With Ovarian Cancer. Int J Gynecol Cancer 2013; 23: 839-45.
13. Effenberger KE, Schroeder C, Eulenburg C, et al. Disseminated tumor cells in pancreatic cancer-an independent prognosticator of disease progression and survival. Int J Cancer 2012; 131: E475-83.
14. Vashist YK, Effenberger KE, Vettorazzi E, et al. Disseminated tumor cells in bone marrow and the natural course of resected esophageal cancer. Ann Surg 2012; 255: 1105-12.
15. Dvoretsky PM, Richards KA, Angel C, et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol 1988; 19: 57-63.
16. Kim K, Cho SY, Kim BJ, et al. The type of metastasis is a prognostic factor in disseminated cervical cancer. J Gynecol Oncol 2010; 21: 186-90.
17. Rahbari NN, Aigner M, Thorlund K, et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 2010; 138: 1714-26.
18. Sehouli J, Konsgen D, Nimpsch R, et al. Prognostic significance of epithelial cells in the blood of patients with gynaecological malignancies. Anticancer Res 2003; 23: 4133-40.
19. Scheungraber C, Muller B, Kohler C, et al. Detection of disseminated tumor cells in patients with cervical cancer. J Cancer Res Clin Oncol 2002; 128: 329-35.
20. Tseng CJ, Pao CC, Lin JD, et al. Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis. J Clin Oncol 1999; 17: 1391-6.
21. Zhang X, Wang C, Wang L, et al. Detection of circulating Bmi-1 mRNA in plasma and its potential diagnostic and prognostic value for uterine cervical cancer. Int J Cancer 2012; 131: 165-72.
22. Meng S, Tripathy D, Frenkel EP, et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 2004; 10: 8152-62.
23. Janni W, Vogl FD, Wiedswang G, et al. Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse-a European pooled analysis. Clin Cancer Res 2011; 17: 2967-76.
24. Hartkopf AD, Wagner P, Wallwiener D, et al. Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer. Anticancer Res 2011; 31: 979-84.
25. Sturgeon CM, Duffy MJ, Hofmann BR, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 2010; 56: e1-48.
26. Fehm T, Solomayer EF, Meng S, et al. Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells. Cytotherapy 2005; 7: 171-85.
27. Dong SM, Pai SI, Rha SH, et al. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev 2002; 11: 3-6.
28. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9.
29. Hafner N, Gajda M, Altgassen C, et al. HPV16-E6 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR. Int J Cancer 2007; 120: 1842-6.
30. Tong YQ, Liu B, Zheng HY, et al. Overexpression of BMI-1 is associated with poor prognosis in cervical cancer. Asia Pac J Clin Oncol 2012; 8: e55-62.